Entry |
|
Name |
Levosulpiride (INN); Levopraid (TN) |
Formula |
C15H23N3O4S
|
Exact mass |
341.1409
|
Mol weight |
341.4258
|
Structure |

|
Simcomp |
|
Class |
Neuropsychiatric agent
DG01478 Dopamine antagonist
DG01474 Dopamine D2-receptor antagonist
DG03200 Antipsychotic agent
DG01941 Benzamide antipsychotic
|
Remark |
|
Efficacy |
Antipsychotic, Dopamine receptor antagonist |
Comment |
Benzamide derivative
See [DR: D01226]
|
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
|
Interaction |
|
Structure map |
map07213 | Dopamine receptor agonists/antagonists |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N05 PSYCHOLEPTICS
N05A ANTIPSYCHOTICS
N05AL Benzamides
N05AL07 Levosulpiride
D07312 Levosulpiride (INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01478 Dopamine antagonist
DG01474 Dopamine D2-receptor antagonist
D07312 Levosulpiride
DG03200 Antipsychotic agent
DG01941 Benzamide antipsychotic
D07312 Levosulpiride
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Dopamine
DRD2
D07312 Levosulpiride (INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 23
1 C8y C 10.7800 -18.5500
2 C8x C 10.7800 -17.1500
3 C8x C 11.9700 -16.4500
4 C8y C 13.2300 -17.1500
5 C8y C 13.2300 -18.5500
6 C8x C 11.9700 -19.2500
7 C5a C 14.4200 -19.2500
8 N1b N 15.6100 -18.5500
9 O5a O 14.4200 -20.6500
10 O2a O 14.4200 -16.4500
11 C1b C 16.8000 -19.2500
12 C1y C 17.9900 -18.5500
13 C1x C 18.4100 -17.2200
14 C1x C 19.8100 -17.2200
15 C1x C 20.3000 -18.5500
16 N1y N 19.1800 -19.3900
17 C1b C 19.1800 -20.7900
18 C1a C 20.3700 -21.4900
19 S4a S 9.5900 -19.2500
20 N1a N 8.3300 -19.9500
21 O3c O 8.8900 -18.0600
22 O3c O 10.5700 -20.2300
23 C1a C 14.4200 -15.0500
BOND 24
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 5 7 1
8 7 8 1
9 7 9 2
10 4 10 1
11 8 11 1
12 12 11 1 #Down
13 12 13 1
14 13 14 1
15 14 15 1
16 15 16 1
17 12 16 1
18 16 17 1
19 17 18 1
20 1 19 1
21 19 20 1
22 19 21 2
23 19 22 2
24 10 23 1
|